Correlation Between Payoneer Global and MIRA Pharmaceuticals,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Payoneer Global and MIRA Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Payoneer Global and MIRA Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Payoneer Global and MIRA Pharmaceuticals, Common, you can compare the effects of market volatilities on Payoneer Global and MIRA Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Payoneer Global with a short position of MIRA Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Payoneer Global and MIRA Pharmaceuticals,.

Diversification Opportunities for Payoneer Global and MIRA Pharmaceuticals,

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Payoneer and MIRA is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Payoneer Global and MIRA Pharmaceuticals, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MIRA Pharmaceuticals, and Payoneer Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Payoneer Global are associated (or correlated) with MIRA Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MIRA Pharmaceuticals, has no effect on the direction of Payoneer Global i.e., Payoneer Global and MIRA Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Payoneer Global and MIRA Pharmaceuticals,

Given the investment horizon of 90 days Payoneer Global is expected to under-perform the MIRA Pharmaceuticals,. But the stock apears to be less risky and, when comparing its historical volatility, Payoneer Global is 1.89 times less risky than MIRA Pharmaceuticals,. The stock trades about -0.14 of its potential returns per unit of risk. The MIRA Pharmaceuticals, Common is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  105.00  in MIRA Pharmaceuticals, Common on December 22, 2024 and sell it today you would earn a total of  23.00  from holding MIRA Pharmaceuticals, Common or generate 21.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Payoneer Global  vs.  MIRA Pharmaceuticals, Common

 Performance 
       Timeline  
Payoneer Global 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Payoneer Global has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
MIRA Pharmaceuticals, 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in MIRA Pharmaceuticals, Common are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, MIRA Pharmaceuticals, sustained solid returns over the last few months and may actually be approaching a breakup point.

Payoneer Global and MIRA Pharmaceuticals, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Payoneer Global and MIRA Pharmaceuticals,

The main advantage of trading using opposite Payoneer Global and MIRA Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Payoneer Global position performs unexpectedly, MIRA Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MIRA Pharmaceuticals, will offset losses from the drop in MIRA Pharmaceuticals,'s long position.
The idea behind Payoneer Global and MIRA Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stocks Directory
Find actively traded stocks across global markets